Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.56USD
20 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.56
Open
$0.55
Day's High
$0.56
Day's Low
$0.55
Volume
14,412
Avg. Vol
43,794
52-wk High
$3.34
52-wk Low
$0.54

Latest Key Developments (Source: Significant Developments)

Acasti Pharma Files For Mixed Shelf Of Up To $50 Mln
Tuesday, 6 Mar 2018 04:50pm EST 

March 6 (Reuters) - Acasti Pharma Inc ::ACASTI PHARMA INC FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING.  Full Article

Acasti Pharma Q3 ‍net Loss 2017 Was $0.40 Per Share​
Tuesday, 13 Feb 2018 05:00pm EST 

Feb 13 (Reuters) - Acasti Pharma Inc ::ACASTI PHARMA REPORTS THIRD QUARTER FY 2018 FINANCIAL RESULTS.ACASTI PHARMA INC - ‍NET LOSS FOR QUARTER ENDED DECEMBER 31, 2017 WAS $0.40 PER SHARE​.  Full Article

Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​
Wednesday, 22 Nov 2017 08:00am EST 

Nov 22 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍clarifies term of proposed strategic partnership with China pharmaceutical company​.Acasti - Under proposed term, Chinese pharmaceutical co to be granted exclusive license to commercialize CaPre in certain Asian countries including China​.  Full Article

Acasti Pharma ‍enters into non-binding agreement with China-based pharma
Monday, 20 Nov 2017 08:00am EST 

Nov 20 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc - ‍entered into a non-binding term sheet with a China-based pharmaceutical company​.Acasti Pharma - ‍if definitive agreement is reached, signed, term sheet contemplates co would receive an upfront payment of us$8 million upon signing.Acasti Pharma Inc - ‍if definitive agreement is reached & signed, co would also receive potential additional milestone payments in excess of $125 million​.  Full Article

Acasti Pharma says is offering 11.7 mln common shares‍​
Thursday, 16 Nov 2017 05:36pm EST 

Nov 16 (Reuters) - Acasti Pharma Inc :Says it is offering 11.7 million common shares‍​ - SEC Filing.  Full Article

Acasti Pharma reports Q2 loss per share C‍$0.31​
Monday, 13 Nov 2017 05:30pm EST 

Nov 13 (Reuters) - Acasti Pharma Inc :Acasti Pharma reports second quarter FY 2018 financial results.Acasti Pharma Inc qtrly loss per share C‍$0.31​.  Full Article

Acasti Pharma files for offering of up to $17.25 mln of common stock‍​
Friday, 29 Sep 2017 05:48pm EDT 

Sept 29 (Reuters) - Acasti Pharma Inc :Acasti Pharma Inc files for offering of up to $17.25 million of common stock‍​ - sec filing‍​.  Full Article

Acasti Pharma reports Q1 loss per share c$0.19
Monday, 14 Aug 2017 05:30pm EDT 

Aug 14 (Reuters) - Acasti Pharma Inc -:Acasti Pharma reports first quarter fy 2018 financial results.Q1 loss per share c$0.19.  Full Article

Acasti Pharma reports Q4 and FY 2017 financial results
Tuesday, 6 Jun 2017 04:30pm EDT 

June 6 (Reuters) - Acasti Pharma Inc ::Acasti Pharma reports fourth quarter and full-year 2017 financial results.Acasti Pharma Inc - ‍net loss for three-month period ended february 28, 2017 was $0.23 loss per share​.  Full Article

Acasti Pharma says CaPre Phase 3 on track to start in late 2017
Thursday, 30 Mar 2017 08:15am EDT 

Acasti Pharma Inc : Acasti Pharma provides update on capre phase 3 development program . Confirms phase 3 program is on track to start late 2017 .Acasti Pharma - FDA's feedback supports co's plan to conduct two studies instead of one large study, potentially shortening time to NDA submission.  Full Article

BRIEF-Acasti Pharma Files For Mixed Shelf Of Up To $50 Mln

* ACASTI PHARMA INC FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING Source text: (http://bit.ly/2tmbRjP) Further company coverage: